Cargando…

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors

The molecular mechanisms leading to aryl hydrocarbon receptor interacting protein (AIP) mutation-induced aggressive, young-onset growth hormone-secreting pituitary tumors are not fully understood. In this study, we have identified that AIP-mutation-positive tumors are infiltrated by a large number o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barry, Sayka, Carlsen, Eivind, Marques, Pedro, Stiles, Craig E., Gadaleta, Emanuela, Berney, Dan M., Roncaroli, Federico, Chelala, Claude, Solomou, Antonia, Herincs, Maria, Caimari, Francisca, Grossman, Ashley B., Crnogorac-Jurcevic, Tatjana, Haworth, Oliver, Gaston-Massuet, Carles, Korbonits, Márta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755983/ https://www.ncbi.nlm.nih.gov/pubmed/30867568 http://dx.doi.org/10.1038/s41388-019-0779-5

Ejemplares similares

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors
por: Marques, Pedro, et al.
Publicado: (2020)

RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas
por: Garcia-Rendueles, Angela R., et al.
Publicado: (2021)

Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas
por: Garcia-Rendueles, Angela R., et al.
Publicado: (2023)

Risk category system to identify pituitary adenoma patients with AIP mutations
por: Caimari, Francisca, et al.
Publicado: (2018)

Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2018)

SAT-LB056 Is AIP a Tumor Suppressor or an Oncogene? AIP as a Novel Regulator of the Oncogene BCL6 in Diffuse Large B Cell Lymphoma
por: BARRY, SAYKA, et al.
Publicado: (2019)

MON-462 Cytokine Network in Pituitary Adenomas and Its Role in the Tumor Microenvironment: Focus on Macrophages
por: Marques, Pedro, et al.
Publicado: (2019)

SAT-462 AIP Mutation-Positive Patients with Somatotropinomas End up Taller and Requiring Radiotherapy More Often Compared to AIP Mutation-Negative Patients: Data from 784 Familial and Young-Onset Cases
por: Marques, Pedro, et al.
Publicado: (2019)

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2015)

The role of the tumour microenvironment in the angiogenesis of pituitary tumours
por: Marques, Pedro, et al.
Publicado: (2020)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019)

Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family
por: Marques, Pedro, et al.
Publicado: (2018)

Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
por: Dénes, Judit, et al.
Publicado: (2015)

Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
por: Crnogorac-Jurcevic, Tatjana, et al.
Publicado: (2013)

MON-460 Pasireotide Treatment Inhibits Cytokine Release from Pituitary Adenoma-Associated Fibroblasts: Is This Mechanism Playing a Key Role in Its Effect?
por: Marques, Pedro, et al.
Publicado: (2019)

The Pancreatic Expression database: 2011 update
por: Cutts, Rosalind J., et al.
Publicado: (2011)

Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
por: Morgan, Rhodri M. L., et al.
Publicado: (2012)

Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets
por: Chelala, Claude, et al.
Publicado: (2007)

AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation
por: Araujo, Paula Bruna, et al.
Publicado: (2017)

Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families
por: Igreja, Susana, et al.
Publicado: (2010)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019)

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws
por: Gadaleta, Emanuela, et al.
Publicado: (2011)

Increased Population Risk of AIP‐Related Acromegaly and Gigantism in Ireland
por: Radian, Serban, et al.
Publicado: (2016)

ODP368 Hyper-phosphorylation of β-catenin at Serine552: predictive marker of invasion and recurrence of Non-Functioning Pituitary Tumours (NFPTs)
por: Rai, Ashutosh, et al.
Publicado: (2022)

Circulating aryl hydrocarbon receptor-interacting protein (AIP) is independent of GH secretion
por: Stojanovic, Marko, et al.
Publicado: (2019)

AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020)

The Pancreatic Expression Database: 2018 update
por: Marzec, Jacek, et al.
Publicado: (2018)

The pancreatic expression database: recent extensions and updates
por: Dayem Ullah, Abu Z., et al.
Publicado: (2014)

Novel AIP mutation in exon 6 causing acromegaly in a German family
por: Detomas, M., et al.
Publicado: (2023)

Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours
por: Rai, Ashutosh, et al.
Publicado: (2022)

Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas
por: Gaspar, L. M., et al.
Publicado: (2023)

Imprinted Dlk1 dosage as a size determinant of the mammalian pituitary gland
por: Scagliotti, Valeria, et al.
Publicado: (2023)

In vivo bioassay to test the pathogenicity of missense human AIP variants
por: Aflorei, Elena Daniela, et al.
Publicado: (2018)

Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview
por: Bilbao Garay, Ismene, et al.
Publicado: (2020)

THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
por: Wang, Xian, et al.
Publicado: (2023)

AIP gene germline variants in adult Polish patients with apparently sporadic pituitary macroadenomas
por: Trofimiuk-Müldner, Małgorzata, et al.
Publicado: (2023)

How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
por: Trouillas, Jacqueline, et al.
Publicado: (2020)

Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020)

Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism
por: Imran, Syed Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_us8uqsut6tmbb2s38dj85akhra